Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.213EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.213EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.213ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.213ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.341EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.341EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.341ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.341ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.341EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.341EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.341ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.341ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.89EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.89ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.89ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.89EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.89EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.89ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.89ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.326EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.326EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.326ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.326ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.326EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.326EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.326ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.326ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.255EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.255EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.255ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.255ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.255EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.255EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.255ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.255ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.303EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.303EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.303ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.303ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.303EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.303EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used